Role of percutaneous endovascular intervention in acute    limb ischemia

Ahmed Abd-Elsalam Zaki Hammad; Hossam Ahmed Aboul Enein; Ayman Refaat Abdel-Hassib; Abdulaziz Zienulabeden Mohamed

doi:10.53730/ijhs.v6nS4.7578

Authors

Ahmed Abd-Elsalam Zaki Hammad
episico_abdo@yahoo.com
Department of General and Vascular Surgery, El-Monira General Hospital, Cairo, Egypt
Hossam Ahmed Aboul Enein Professor of general and vascular surgery, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
Ayman Refaat Abdel-Hassib Professor of general and vascular surgery, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
Abdulaziz Zienulabeden Mohamed Associate Professor of general and vascular surgery, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt

Keywords:

acute limb ischemia, acute thrombotic ischemia, catheter-directed thrombolysis

Abstract

Acute thrombotic lower limb ischemia is a limb- and life-threatening event. Catheter-directed thrombolysis is now one of the best choices in treatment of such condition. Tissue plasminogen activator like alteplase is a safe and efficient thrombolytic agent. The current study is designed to show its efficacy and safety and to investigate variables that correlate with outcome. This is a prospective observational study. It included patients with acute thrombotic lower limb ischemia. Exclusion criteria include acute lower limb ischemia due to embolism, trauma, arterial dissection, complicated aneurysm. Patients with bleeding risk, history of recent intracranial bleeding, massive gangrene, or uncontrolled hypertension are also excluded. The study is approved by ethical committee of Beni-Suef University and assigned number FWA00015574. Primary end points were technical success, clinical success, and limb salvage. Secondary end points were procedural complications. A total of 36 patients were enrolled in the study from March 2019 to February 2021 in Beni-Suef University hospital. It included 21 male patients (58.33%) and 15 female patients (41.67%). The patient’s mean age was 58.42 years. The patient’s mean BMI was 31.56.

Downloads

Download data is not yet available.

References

Berridge DC, Kessel DO and Robertson I (2013): Surgery versus thrombolysis for initial management of acute limb ischemia. Cochrane Database Syst Rev, Issue 6. Art. No.: CD002784.

Branco BC, Montero-Baker MF and Mills JL Sr. (2015): The pros and cons of endovascular and open surgical treatments for patients with acute limb ischemia. J CARDIOVASC SURG; 56: 1–2.

Byrne RM, Taha AG, Avgerinos E, Marone LK, Makaroun MS and Chaer RA. (2014): Contemporary outcomes of endovascular interventions for acute limb ischemia. J Vasc Surg.; 59(4): 988–995.

Earnshaw JJ, Whitman B and Foy C (2004): National audit of thrombolysis for acute leg ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg; 39 (5): 1018–25.

Enezate TH, Omran J, Mahmud E, Patel M, Abu-Fadel MS, White CJ and Al-Dadah AS. (2017): Endovascular versus surgical treatment for acute limb ischemia: A systematic review and meta-analysis of clinical trials. Cardiovasc. Diagn. Ther.; 7: 264–271.

Kuoppala M, Franzén S, Lindblad B and Acosta S. (2008): Long-term prognostic factors after thrombolysis for lower limb ischemia. J Vasc Surg.; 47(6): 1243–50.

Lian WS, Das SK, Hu XX, Zhang XJ, Xie XY and Li MQ. (2020): Efficacy of intra-arterial catheter directed thrombolysis for popliteal and infrapopliteal acute limb ischemia. J Vasc Surg.; 71(1): 141–148.

Lyden SP. (2010): Endovascular treatment of acute limb ischemia: review of current plasminogen activators and mechanical thrombectomy devices. Perspect Vasc Surg Endovasc Ther.; 22: 219–22.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007): TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J VascSurg; 45 Suppl S: S5–S67.

Ouriel K, Veith FJ and Sasahara AA. (1998): A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med.; 338(16): 1105–11.

Plate G, Oredsson S, Lanke J. (2009): When is thrombolysis for acute lower limb ischemia worthwhile? Eur J Vasc Endovasc Surg; 37:206–212.

Rajan DK, Patel NH, Valji K, Cardella JF, Bakal C, Brown D, et al. (2005): Quality improvement guidelines for percutaneous management of acute limb ischemia. J Vasc Interv Radiol; 16:585–595.

Robertson I, Kessel DO and Berridge DC. (2013): Fibrinolytic agents for peripheral arterial occlusion. Cochrane Database Syst Rev; 12:CD001099.

Urbak L, de la Motte L, Rørdam P, Siddiqi A and Sillesen H. (2017): Catheter Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment. Ann Vasc Dis.; 10(2): 125–131.